Proposal for Parental Guidance and Early Stimulation in Children With Congenital Heart Disease: Randomized Trial
1 other identifier
interventional
44
1 country
1
Brief Summary
Problem: With the increased survival rate of children with congenital heart disease, other health problems, in addition to the clinic, have emerged, such as the risks of developmental delay to which these children are exposed. There is a need for low-cost intervention studies that seek to minimize these risks. Objective: To evaluate the effect of an early stimulation program using parents as vectors of intervention, on the neurodevelopment of children with CHD Methodology: Randomized clinical trial, conducted with 44 dyads of parents-babies with CH considered as medium and high risk for developmental delays according to the guidelines of the American Heart Association (2012). The study will consist of two groups G1 (Intervention) and G2 (controls). G1 parents will receive guidance for 6 weeks of stimulation activities and will be instructed to keep an online execution diary, direct with the researcher through videos, and messages via cell phone. G2 parents will receive the standard guidelines currently used in pediatric cardiology clinics. Children from both groups will be assessed at the beginning and end of the 6 weeks by the Bayley Baby and Toddler Development Scales (3rd Edition). A questionnaire on the applicability of the protocol will be administered to the parents of the intervention group Expected results: Better neuropsychomotor performance in children after applying the early stimulation protocol. Perspectives: Create a body of information that can serve as a basis for the formulation of policies for intervention and surveillance of the development of this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 25, 2019
CompletedFirst Posted
Study publicly available on registry
November 5, 2019
CompletedStudy Start
First participant enrolled
November 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2020
CompletedJune 23, 2023
July 1, 2020
9 months
June 25, 2019
June 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference between groups
Early intervention prevents developmental delays in children with congenital heart disease.
6 moths
Study Arms (1)
Comparison between intervention and control group
OTHERThe subjects will be randomized to two groups, intervention group (IG) and control group (CG). Each day GI Parents-Baby receives guidance for 6 weeks of stimulation activities and will be instructed to keep an online execution diary, directly with the researcher of videos and messages via cell phone. "Parents" is understood as a generalist nomenclature and will be considered a parent, mother or principal. GC subjects receive standard guidance from the pediatric and pediatric cardiology clinic.
Interventions
A parenting guidance booklet will be prepared. It will contain a specific program of stimulation activities for each stage of development in simple language and with illustrations. Subdivided into 4 areas: Cognition, Language, Large Motor and Fine Motor. The duration will be 6 weeks. Parents will participate in 1 individual face-to-face meeting, where they will receive information and clarification on the application of the booklet and will have a mobile communication channel to answer questions throughout the process. Parents will be instructed on the capabilities and limitations of their babies according to the child's congenital heart disease, as well as what is expected within the typical development for this age group and the importance of early stimulation activities in each child in 4 areas of development.
Eligibility Criteria
You may qualify if:
- For babies
- Diagnosis of congenital heart disease up to 3 months old.
- Stable clinical condition (with medical clearance to receive the intervention), For parents
- Parents are literate
- Acceptance of the Responsible to participate in the research.
- Have a mobile device capable of sending and receiving messages and videos.
You may not qualify if:
- For babies
- Suspected or diagnosed genetic syndrome;
- Musculoskeletal or neurological malformation associated
- inability to establish a primary caregiver as in the case of baby under state supervision.
- for parents
- Illiteracy
- Presence of deafness, blindness or physical disability, when another family member cannot be responsible for the application of the protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto de cardiologia de porto alegre
Porto Alegre, Rio Grande do Sul, 90040-001, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fernanda Lucchese, Doutora
Instituto de cardiologia de porto alegre
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 25, 2019
First Posted
November 5, 2019
Study Start
November 30, 2019
Primary Completion
August 30, 2020
Study Completion
August 30, 2020
Last Updated
June 23, 2023
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share